• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Evolent Health Appoints Seth R. Frank as Vice President, Investor Relations

    12/1/21 8:00:00 AM ET
    $EVH
    $HNGR
    $MDRX
    Other Consumer Services
    Consumer Discretionary
    Medical Specialities
    Health Care
    Get the next $EVH alert in real time by email

    WASHINGTON, Dec. 1, 2021 /PRNewswire/ -- Evolent Health, Inc. (NYSE:EVH) ("Evolent"), a health care company that delivers proven clinical and administrative solutions to payers and providers, today announced that Seth R. Frank has joined the company as Vice President, Investor Relations, effective immediately. Reporting to John Johnson, Evolent's Chief Financial Officer, Seth will lead Evolent's investor relations (IR) strategy and oversee its relationships with the investment community.

    "Seth provides a demonstrated track record of proactive, finance-driven leadership in health care investor relations to Evolent," said Evolent Health Chief Financial Officer John Johnson. "He brings long-term relationships with institutional investors, analysts and other stakeholders across the health care services sector, as well as health care information technology specifically. With his expertise in originating strategic IR programs, we anticipate Seth will accelerate the investment community's knowledge of Evolent's business as we continue to deliver on our strategy to create long-term value for shareholders." 

    Seth joins Evolent from Hanger, Inc. (NYSE:HNGR), a leading provider of orthotic and prosthetic services, where he served as Vice President of Treasury and Investor Relations for nearly four years. Previously, Seth was Vice President of Investor Relations at Allscripts (NASDAQ:MDRX), a health care information technology company, for nearly eight years; prior to that, Seth worked in several other investor relations and financial communications roles. Prior to beginning his corporate career in 2006, Seth was an equity analyst and capital markets professional at several firms including Morgan Stanley, SunTrust and A.G. Edwards where he covered the health care information technology, distribution and medical technology industries. Seth received his undergraduate degree from Emory University, an M.S. as a Physician Assistant from the University of Colorado School of Medicine, and also attended the Master of Public Health program at Yale University. He holds the Investor Relations Charter (IRC®) from the National Investor Relations Institute. 

    Evolent Health Logo (PRNewsfoto/Evolent Health)

    About Evolent Health

    Evolent Health (NYSE:EVH) delivers proven clinical and administrative solutions that improve whole-person health while making health care simpler and more affordable. Our solutions encompass total cost of care management, specialty care management, and administrative simplification. Evolent serves a national base of leading payers and providers, is the first company to receive the National Committee for Quality Assurance's Population Health Program Accreditation, and is consistently recognized as a top place to work in health care nationally. Learn more about how Evolent is changing the way health care is delivered by visiting evolenthealth.com.

    CONTACTS:

    Investors:

    Seth R. Frank

    Vice President, Investor Relations

    Evolent Health, Inc.

    [email protected]

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/evolent-health-appoints-seth-r-frank-as-vice-president-investor-relations-301434968.html

    SOURCE Evolent Health

    Get the next $EVH alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $EVH
    $HNGR
    $MDRX

    CompanyDatePrice TargetRatingAnalyst
    Evolent Health Inc
    $EVH
    1/10/2025$15.00Buy
    Needham
    Evolent Health Inc
    $EVH
    12/3/2024$36.00 → $29.00Buy
    BTIG Research
    Evolent Health Inc
    $EVH
    11/8/2024$38.00 → $16.00Overweight → Equal-Weight
    Stephens
    Evolent Health Inc
    $EVH
    10/11/2024$35.00Overweight
    KeyBanc Capital Markets
    Evolent Health Inc
    $EVH
    8/9/2024$28.00 → $33.00Hold → Buy
    Truist
    Evolent Health Inc
    $EVH
    4/22/2024$40.00Buy
    Citigroup
    Veradigm Inc.
    $MDRX
    3/19/2024$15.00 → $10.00Buy → Hold
    Deutsche Bank
    Evolent Health Inc
    $EVH
    3/1/2024$45.00Outperform
    Oppenheimer
    More analyst ratings

    $EVH
    $HNGR
    $MDRX
    SEC Filings

    See more
    • Evolent Health Inc filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

      8-K - Evolent Health, Inc. (0001628908) (Filer)

      6/20/25 6:32:06 AM ET
      $EVH
      Other Consumer Services
      Consumer Discretionary
    • Veradigm Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation

      8-K - Veradigm Inc. (0001124804) (Filer)

      6/20/25 6:06:49 AM ET
      $MDRX
      EDP Services
      Technology
    • SEC Form S-8 filed by Evolent Health Inc

      S-8 - Evolent Health, Inc. (0001628908) (Filer)

      6/10/25 5:21:58 PM ET
      $EVH
      Other Consumer Services
      Consumer Discretionary